Via The Seattle Times:
The agency cleared J&J's Invokana tablets for adults with Type 2 diabetes, which affects an estimated 26 million Americans. The once-a-day medication works by blocking the kidneys from reabsorbing sugar, which occurs at higher levels in patients with diabetes than in healthy patients. Regulators highlighted the drug as the first in a new class of medications that could help address the nation's growing diabetes epidemic.
FDA OKs first-of-its-kind diabetes drug from J&J | Health | The Seattle Times
More help on the way for Type 2 diabetics?
